5 takeaways from the FHSAA's football class release for 2026-27 seasons

The FHSAA released the tentative football classes for the next two-year cycle Defending state champions Chaminade-Madonna and ...
The Manila Times

Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI™ (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Ref…

CR in newly diagnosed NPM1-m AML, with 68% (17/25) of CRc responders achieving molecular MRD negativity by central NGS ...
The Manila Times

Syndax Highlights Leadership in Menin Inhibition at ASH 2025 with Multiple Revuforj® (revumenib) Presentations Spanning the Acute Leukemia Treatment Continuum

First real-world evidence for a menin inhibitor shows 77% ORR (10/13), 31% (4/13) CR/CRh, 75% (9/12) MRD negativity, and favorable tolerability among primarily R/R NPM1m, KMT2Ar, and NUP98r acute leuk ...

New FHSAA classes bring change for Sarasota, Manatee football teams

The FHSAA eliminated Class 7A for football, shifting the classes, districts and regions for many Sarasota and Manatee ...

Ranchi schools begin pre-board exams

In Ranchi, schools are rolling out a phased approach to pre-board exams for Class X and XII students. This innovative method ...

NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint inhibitors, a multi-billion dollar drug class hampered by widespread ...